Traws Pharma Inc.

TRAW | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.49

-$0.05 (-8.50%)

At close: Sep 18, 2026, 4:00 PM ET

$0.50

+$0.01 (+2.00%)

After-hours: Sep 18, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-8.50%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $7.46M

1D Range

0.48 0.54

52W Range

0.43 3.27

Valuation (TTM)

PE -0.56

PB -1.40

EV/EBITDA -0.30

Valuation (NTM)

Forward PE N/A

Forward PEG -0.37

Price Target $1

Cash Flow

FCF Yield -71.5%

SBC Adj. FCF Yield -84.4%

SBC Impact -18.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -85.8% | -69.4%

Dil EPS 3Y | 5Y 76.0% | 97.9%

FCF 3Y | 5Y 16.8% | 4.6%

Returns

ROA -128.7%

ROE 353.4%

ROIC 283.3%

Financial Health

Net Cash

$3.13M

Current Ratio 0.43

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections a...

Sector Healthcare

Industry Biotechnology

Employees 7

IPO Date Jul 24, 2013

Website www.trawspharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Upside

+104.08%

Buy (0)

Hold (2)

Sell (0)

Analyst Details ➞